James T. Borello RIA’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.5K Sell
619
-194
-24% -$6.94K 0.01% 372
2026
Q2
$27.5K Buy
813
+194
+31% +$6.46K 0.01% 335
2026
Q1
$18.6K Buy
619
+610
+6,778% +$19.6K ﹤0.01% 393
2025
Q4
$281 Buy
+9
New +$222 ﹤0.01% 985

Other funds holding TEVA

James T. Borello RIA's TEVA Position: Q3 2026 in Review

James T. Borello RIA reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 24% in Q3 2026, selling an estimated $6.94K and leaving 619 shares worth $24.5K. The position accounts for 0.01% of the portfolio, ranked #372.

James T. Borello RIA first reported a position in TEVA in Q4 2025 and has held it in 4 quarters since. The position peaked at $27.5K in Q2 2026. 49 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • James T. Borello RIA held 619 shares of Teva Pharmaceutical Industries Limited worth $24.5K as of Q3 2026.
  • James T. Borello RIA sold 194 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $6.94K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of James T. Borello RIA's portfolio in Q3 2026, its #372 holding.
  • James T. Borello RIA first reported a position in Teva Pharmaceutical Industries Limited in Q4 2025 and has held it in 4 quarters since.
  • James T. Borello RIA's Teva Pharmaceutical Industries Limited position peaked at $27.5K in Q2 2026.
  • 49 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.